Heart and Vessels

, Volume 7, Issue 4, pp 189–195 | Cite as

Moderation of myocardial ischemia reperfusion injury by calcium channel and calmodulin receptor inhibition

  • Yataka Kimura
  • Richard M. Engelman
  • John Rousou
  • Joseph Flack
  • Jaisimha Iyengar
  • Dipak K. Das
Originals

Summary

Intracellular Ca2+ accumulation is implicated in the pathogenesis of myocardial reperfusion injury. To study approaches designed to modify Ca2+ uptake during coronary revascularization after acute infarction, a pig heart surgical infarct model (left anterior descending artery occlusion for 60 min) was subjected to 60 min hypothermic potassium cardioplegic arrest, followed by 60 min of global reperfusion. Four groups of six hearts each were studied in a randomized manner, i.e., cardioplegia alone (control), cardioplegia + 10 µM diltiazem (Ca2+ slow channel blocker), cardioplegia + 10 µM trifluoperazine (TFP), (a Ca2+-calmodulin antagonist), and cardioplegia + diltiazem (10 µM) + TFP (10 µM). Left ventricular contractility (global and segmental), metabolism (coronary blood flow and O2 consumption), and creatine kinase generation were measured during reperfusion. Both the Ca2+ channel blocker, diltiazem, and the calmodulin antagonist, TFP, improved myocardial global and regional function as well as myocardial metabolism. While diltiazem better restored global and regional contractility, trifluoperazine had a greater effect on coronary blood flow and myocardial oxygen consumption. Enzyme release and lipid peroxidation were equally moderated by both drugs. From this study it can be concluded that Ca2+ influx does play a role in ischemic and reperfusion injury. The mechanisms of its effect are complex, but can be successfully antagonized by Ca2+ blockers as well as by calmodulin antagonists, with improved myocardial preservation.

Key words

Myocardial reperfusion injury Ca2+ Channel blockers Calmodulin antagonists Myocardial infarction 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Opie LH (1989) Proposed role of calcium in reperfusion injury. Int J Cardiol 23:159–164Google Scholar
  2. 2.
    Nayler WG, Panagiotopoulos S, Elz JS, Daly MJ (1983) Calcium-mediated damage during post-ischaemic reperfusion. J Mol Cell Cardiol 20 (Suppl 2):41–54Google Scholar
  3. 3.
    Watts JA, Koch CD, LaNoue KF (1980) Effects of Ca2+ antagonism on energy metabolism: Ca2+ and heart function after ischemia. Am J Physiol 238:H909–H916Google Scholar
  4. 4.
    Bourdillon PD, Pool-Wilson PA (1982) The effects of verapamil, quiescence, and cardioplegia on calcium exchange and mechanical function in ischemic rabbit myocardium. Circ Res 50:360–368Google Scholar
  5. 5.
    Nayler WG, Panagiotopoulos S, Elz JS, Sturrock WJ (1987) Fundamental mechanisms of action of calcium antagonists in myocardial ischemia. Am J Cardiol 59:75B–83BGoogle Scholar
  6. 6.
    Opie L (1992) Myocardial stunning: A role for calcium antagonists during reperfusion. Cardiovasc Res 26:20–24Google Scholar
  7. 7.
    Weishaar RE, Bing RJ (1980) The beneficial effect of a calcium channel blocker, Diltiazem, on the ischemic-reperfused heart. J Mol Cell Cardiol 12:993–1009Google Scholar
  8. 8.
    Clark RE, Christlieb IY, Henry PD, Fischer AE, Nora JD, Williamson JR, Sobel BE (1979) Nifedipine: A myocardial protective agent. Am J Cardiol 44:825–831Google Scholar
  9. 9.
    Means AR, Dedman JR (1980) Calmodulin — an intracellular calcium receptor. Nature 285:73–77Google Scholar
  10. 10.
    Higgins AJ, Blackburn KJ (1984) Prevention of reperfusion damage in working rat hearts by calcium antagonists and calmodulin antagonists. J Mol Cell Cardiol 16:427–438Google Scholar
  11. 11.
    McCall D (1987) Excitation-contraction coupling in cardiac and vascular smooth muscle: Modification by calcium-entry blockade. Circulation 75:V3-V14Google Scholar
  12. 12.
    Otani H, Engelman RM, Rousou JA, Breyer RH, Clement R, Prasad R, Klar J, Das DK (1989) Improvement of myocardial function by trifluoperazine, a calmodulin antagonist, after acute coronary artery occlusion and coronary revascularization. J Thorac Cardiovasc Surg 97:267–274Google Scholar
  13. 13.
    Edoute Y, van der Merwe EL, Sanan D, Kotze JC, van Niekerk I, Lochner A (1983) Normothermic ischaemic cardiac arrest and reperfusion of the isolated working heart: Effect of chlorpromazine on functional, metabolic and morphological recovery. J Mol Cell Cardiol 15:603–620Google Scholar
  14. 14.
    Engelman RM, Prasad MR, Rousou JA, Breyer RH, Bagchi M, Das DK (1989) Steroid-induced myocardial preservation is associated with decreased cell membrane microviscosity. Circulation 80:III-36–III-43Google Scholar
  15. 15.
    Otani H, Engelman RM, Rousou JA, Breyer RH, Lemeschow S, Das DK (1986) Cardiac performance during reperfusion improved by pretreatment with oxygen free-radical scavengers. J Thorac Cardiovasc Surg 91:290–295Google Scholar
  16. 16.
    Das DK, Engelman RM, Flansaas D, Otani H, Rousou J, Breyer RH (1987) Developmental profiles of protective mechanisms of heart against peroxidative injury. Basic Res Cardiol 82:36–50Google Scholar
  17. 17.
    Prasad MR, Clement R, Otani H, Jones R, Das DK, Engelman RM, Breyer RH, Rousou JA (1988) Improved myocardial performance induced by clofibrate during reperfusion after acute myocardial infarction. Can J Physiol Pharmacol 66:1518–1523Google Scholar
  18. 18.
    Nayler WG, Sturrock WJ (1984) An inhibitory effect of verapamil and diltiazem on the release of noradrenaline from ischaemic and reperfused hearts. J Mol Cell Cardiol 16:331–343Google Scholar
  19. 19.
    Murphy KM, Snyder SH (1982) Calcium antagonist receptor binding sites labeled with (3H) nitrendipine. Eur J Pharmacol 77:201–202Google Scholar
  20. 20.
    Nakaya H, Schwartz A, Millard RW (1981) Cardiac effects of equihypotensive doses of calcium channel blocking agents in conscious dogs. Circulation 64 (Suppl IV):IV-176Google Scholar
  21. 21.
    Nakaya H, Schwartz A, Millard RW (1983) Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Diltiazem, verapamil, and nifedipine compared. Circ Res 52:302–311Google Scholar
  22. 22.
    Millard RW, Grupp G, Grupp IL, DiSalvo J, DePover A, Schwartz A (1983) Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity. Circ Res 52:I-29–I-39Google Scholar
  23. 23.
    Lochner A, van Niekerk I, Kotze JC (1985) Normothermic ischaemic cardiac arrest of the isolated perfused rat heart: Effects of trifluoperazine and lysolecithin on mechanical and metabolic recovery. Basic Res Cardiol 80:363–376Google Scholar
  24. 24.
    Schaffer SW, Burton KP, Jones HP, Oei HH (1983) Phenothiazine protection in calcium overload-induced heart failure: A possible role for calmodulin. Am J Physiol 244:H-328–H-334Google Scholar
  25. 25.
    Carafoli E (1985) Calmodulin in the regulation of calcium fluxes in cardiac sarcolemma. Adv Myocardiol 5:97–101Google Scholar
  26. 26.
    Przyklenk K, Kloner RA (1989) “Reperfusion injury” by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow. Circ Res 64:86–96Google Scholar
  27. 27.
    Rothenberg RJ (1987) Effects of calmodulin inhibitors on rabbit synociocyte phospholipase A2. Prostaglandins Leukot Med 29:61–69Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • Yataka Kimura
    • 1
    • 2
  • Richard M. Engelman
    • 1
    • 2
  • John Rousou
    • 1
    • 2
  • Joseph Flack
    • 1
    • 2
  • Jaisimha Iyengar
    • 1
    • 2
  • Dipak K. Das
    • 1
    • 2
  1. 1.Cardiovascular Division, Department of Surgery, Surgical Research CenterUniversity of Connecticut School of MedicineFarmingtonUSA
  2. 2.Baystate Medical CenterSpringfieldUSA

Personalised recommendations